BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36253533)

  • 1. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.
    Stoffel EM; Ford B; Mercado RC; Punglia D; Kohlmann W; Conrad P; Blanco A; Shannon KM; Powell M; Gruber SB; Terdiman J; Chung DC; Syngal S
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):333-8. PubMed ID: 18258490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
    Sharaf RN; Myer P; Stave CD; Diamond LC; Ladabaum U
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1093-100. PubMed ID: 23669308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
    Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
    BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
    Öfverholm A; Karlsson P; Rosén A
    Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.
    Young AL; Butow PN; Tucker KM; Wakefield CE; Healey E; Williams R
    BMJ Open; 2020 Feb; 10(2):e033127. PubMed ID: 32102811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives.
    Dilzell K; Kingham K; Ormond K; Ladabaum U
    Fam Cancer; 2014 Sep; 13(3):381-9. PubMed ID: 24770865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.
    Nääs C; von Salomé J; Rosén A
    Eur J Hum Genet; 2024 Apr; 32(4):448-455. PubMed ID: 38308085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.
    van den Heuvel LM; van Teijlingen MO; van der Roest W; van Langen IM; Smets EMA; van Tintelen JP; Christiaans I
    Circ Genom Precis Med; 2020 Oct; 13(5):524-530. PubMed ID: 33079600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating family communication about predictive genetic testing: probands' perceptions.
    Gaff CL; Collins V; Symes T; Halliday J
    J Genet Couns; 2005 Apr; 14(2):133-40. PubMed ID: 15959644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.